JUNSHI BIO (688180.SH): Shanghai Tan Ying and Shanghai Tan Zheng plan to reduce their holdings of the company's shares by no more than 0.75%.
Junshi Biosciences (688180.SH) announced that Shanghai TanYing and Shanghai TanZheng have a long-term optimistic view on the company's development, because...
JUNSHI BIO (688180.SH) announced that Shanghai Tanying and Shanghai Tanzheng are optimistic about the company's development in the long term. Due to the fund's term and liquidity arrangements, Shanghai Tanying and Shanghai Tanzheng plan to reduce their holdings of the company's shares in a total amount not exceeding 739,270 shares through centralized bidding and bulk trading, with a cumulative reduction ratio not exceeding 0.75% of the total share capital of the company.
Related Articles

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


